ReviewJournal of hematology & oncology2011

Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space.

A Oliver SartorPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.